Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for Hepatitis C virus in people with HIV.
Mathieu Chalouni(Harvard University), Sara Lodi, Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Johannes Nemeth(University of Zurich), Anders Boyd, Bernard Surial(University of Bern), Christopher T. Rentsch(University of London), Inmaculada Jarrín(Instituto de Salud Carlos III), Sophia M. Rein(Harvard University), Robert Zangerle(Universität Innsbruck), Jessie Torgersen(Center for Clinical Research (United States)), Miguel A. Hernán(Harvard University), Marc van der Valk(Academic Medical Center), Antonella D'arminio Monforte, Juan Berenguer, Marina B Klein, Daniela K Van Santen, Jim Young, Roger W Logan, Benjamin Linas, Giota Touloumi, M John Gill, José M Miro, Linda Wittkop(Université de Bordeaux), Antonios Papadopoulos, Rachel Epstein(Boston University)
Cited by 0
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Vitamin D intake and incidence of multiple sclerosis
|Neurology|2004|1.1k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Observational Studies Analyzed Like Randomized Experiments
|Epidemiology|2008|814